T. Schmeiser

发表

Streptococcal bacteremia in adult patients with leukemia undergoing aggressive chemotherapy. A review of 55 cases

W. Kern, E. Kurrle, T. Schmeiser, 1990, Infection.

Low incidence of invasive fungal infections after bone marrow transplantation in patients receiving amphotericin B inhalations during neutropenia

H. Heimpel, W. Kern, R. Arnold, 2005, Annals of Hematology.

Once-daily versus thrice-daily dosing of netilmicin in combination with beta-lactam antibiotics as empirical therapy for febrile neutropenic patients.

W. Gaus, W. Kern, T. Moritz, 1993, The Journal of antimicrobial chemotherapy.

Cardiac toxicity of bone marrow transplantation: predictive value of cardiologic evaluation before transplant.

M. Clausen, B. Hertenstein, D. Bunjes, 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Intensive care therapy for patients with hematological diseases.

H. Heimpel, B. Anger, T. Schmeiser, 1987, Haematology and blood transfusion.

EVIDENCE FOR THE INVOLVEMENT OF HOST‐DERIVED OKT8‐POSITIVE T CELLS IN THE REJECTION OF T‐DEPLETED, HLA‐IDENTICAL BONE MARROW GRAFTS

H. Heimpel, F. Porzsolt, D. Bunjes, 1987, Transplantation.

COAGULATION FACTOR XIII A AND B SUBUNITS IN BONE MARROW AND LIVER TRANSPLANTATION

A. Wölpl, H. Lattke, P. Board, 1987, Transplantation.

T‐cell depletion versus methotrexate as GvHD‐prophylaxis in allogeneic bone marrow transplantation for leukaemia

H. Heimpel, B. Hertenstein, D. Bunjes, 1988, European journal of haematology.

Fatal B-cell lymphoproliferative syndrome in allogeneic marrow graft recipients

H. Müller-Hermelink, W. Friedrich, C. Bartram, 1991, Virchows Archiv. B, Cell pathology including molecular pathology.

Hemopoietic reconstitution after bone marrow transplantation.

H. Heimpel, G. Pabst, N. Frickhofen, 1986, Experimental hematology.

Infectious complications after allogeneic bone marrow transplantation with and without T-cell depletion of donor marrow

B. Hertenstein, D. Bunjes, R. Arnold, 1989, Infection.

Antimicrobial prophylaxis in neutropenic patients after bone marrow transplantation

H. Heimpel, R. Arnold, D. Krieger, 2005, Infection.

Norfloxacin for prevention of bacterial infections during severe granulocytopenia after bone marrow transplantation.

H. Heimpel, B. Hertenstein, D. Bunjes, 1988, Scandinavian journal of infectious diseases.

Cytomegalovirus (CMV) infections in patients receiving CMV-IgG-hyperimmunoglobulin prophylaxis after bone-marrow transplantation

H. Heimpel, B. Hertenstein, D. Bunjes, 1987, Klinische Wochenschrift.

Ex vivo T‐cell depletion with the monoclonal antibody Campath‐1 plus human complement effectively prevents acute graft‐versus‐host disease in allogeneic bone marrow transplantation

H. Heimpel, G. Hale, H. Waldmann, 1986, British journal of haematology.

CYCLOSPORINE AS AN ALTERNATIVE TO CYCLOPHOSPHAMIDE IN THE TREATMENT OF CHRONIC GRAFT‐VERSUS‐HOST DISEASE

H. Heimpel, R. Arnold, D. Bunjes, 1986, Transplantation.

TREATMENT OF SEVERE ACUTE GVHD WITH HIGH-DOSE ATG

H. Heimpel, E. Kohne, R. Arnold, 1983 .

Fluoroquinolones for Infection Prevention After Bone Marrow Transplantation

W. Kern, B. Hertenstein, D. Bunjes, 1994 .

Extramedullary haemopoiesis after bone marrow transplantation.

H. Heimpel, R. Arnold, B. Heymer, 2009, Scandinavian journal of haematology.

Selective decontamination in neutropenic patients

W. Kern, E. Kurrle, T. Schmeiser, 1992, Epidemiology and Infection.

Hematopoietic colony formation after allogeneic bone marrow transplantation: enhancement by cyclosporin A and anti-gamma-(immune) interferon antiserum in vitro.

H. Heimpel, N. Frickhofen, F. Porzsolt, 1986, Experimental hematology.

Thrombotic thrombocytopenic purpura in early pregnancy with maternal and fetal survival

H. Heimpel, E. Seifried, B. Hertenstein, 1992, Annals of Hematology.

ABO-incompatible bone marrow transplantation.

H. Heimpel, H. Northoff, B. Hertenstein, 1992, Beitrage zur Infusionstherapie = Contributions to infusion therapy.

Graft failure after T cell-depleted bone marrow transplantation: clinical and immunological characteristics and response to immunosuppressive therapy.

B. Hertenstein, D. Bunjes, R. Arnold, 1990, Bone marrow transplantation.

Emerging Bacterial Pathogens in Patients with Acute Leukemia: Viridans Streptococci and Non-Fermentative Gram-Negative Bacilli

W. Kern, B. Hertenstein, R. Arnold, 1994 .

Corynebacterium jeikeium bacteremia at a tertiary care center

W. Kern, E. Rozdzinski, E. Kurrle, 1991, Infection.

Randomized comparison of interferon α and hydroxyurea with hydroxyurea monotherapy in chronic myeloid leukemia (CML-study II): prolongation of survival by the combination of interferon α and hydroxyurea

H. Heimpel, J. Hasford, M. Griesshammer, 2003, Leukemia.

[Bone marrow transplantation in panmyelopathy, acute leukemia and chronic myelocytic leukemia: results of the Ulm Transplantation Group].

M. Wannenmacher, W. Friedrich, E. Kohne, 1984, Klinische Wochenschrift.

A simple technique for processing of bone marrow for human marrow transplantation

M. Wiesneth, B. Kubanek, T. Schmeiser, 1982, Blut.

Single-drug oral antibacterial prophylaxis with ofloxacin in BMT recipients.

W. Kern, B. Hertenstein, R. Arnold, 1993, Bone marrow transplantation.